Corbin Timothy J, McCabe James G
Amgen, Inc., Transgenics Division, One Amgen Center Drive, Thousand Oaks, California 93065, USA.
Contemp Top Lab Anim Sci. 2002 Mar;41(2):18-23.
The purpose of this study was to examine the response of rats of different genetic backgrounds to various superovulatory hormonal treatments. Immature Sprague Dawley (SD), FBNF1, and F344 female rats (30 to 35 days of age) were used for this study as representatives of outbred, hybrid, and inbred strains respectively. Animals from each strain were allocated into four groups of hormone treatments as follows: 1) 30 IU pregnant mare serum gonadotrophin (PMSG) intraperitoneally (i.p.) followed 52 h later with 25 IU human chorionic gonadotrophin (HCG) i.p.; 2) 15 IU PMSG i.p. followed 52 h later with 7.5 IU HCG i.p.; 3) 1.0 IU follicle stimulating hormone (FSH) daily via Alzet mini-pumps for 60 h; and 4) 1.0 IU FSH daily via Alzet mini-pumps for 54 h followed by 10 mg luteinizing hormone (LH). The efficacies of the hormone treatments were evaluated using the following criteria: % mated, % ovulated, total oocytes per female, and % fertilized. The % mated of SD rats treated with PMSG(30)+HCG(25) was significantly higher (P < 0.05) than that of animals treated with PMSG(15)+HCG(7.5); in addition, the total oocytes per female was significantly higher (P < 0.05) for SD animals receiving PMSG(30)+HCG(25) than all other treatments. The % ovulated of SD rats was significantly lower (P < 0.05) in response to FSH alone as compared to all other treatments. The % ovulated for FBNF1 rats was significantly greater (P < 0.05) in response to both PMSG+HCG treatments as compared to FSH and FSH+LH. The % ovulated and % fertilized were significantly lower (P < 0.05) in F344 rats treated with FSH alone as compared to all other treatments. F344 rats produced significantly (P < 0.05) more oocytes per female in response to both PMSG+HCG treatments as compared to FSH and FHS+LH. The % ovulated of SD and F344 rats were significantly higher (P < 0.05) than that of FBNF1 rats in response to FSH and FSH+LH. SD rats produced a significantly greater (P < 0.05) number of oocytes per female than did FBNF1 rats in response to PMSG(30)+HCG(25) and a significantly greater (P < 0.05) number of oocytes per female as compared to those of FBNF1 and F344 rats in response to FSH and FSH+LH. The % fertilized of SD and FBNF1 rats were significantly higher (P < 0.05) than that of F344 rats in response to PMSG(15)+HCG(7.5). Our study demonstrates that treatment with PMSG+HCG is an effective method of eliciting superovulatory responses according to most criteria examined. We have also shown that outbred (SD) rats generally produced more oocytes per female in response to hormonal stimulation than did inbred and hybrid rats. Our results indicate that different strains of rats have various degrees of hormone sensitivity and response to different superovulation protocols.
本研究的目的是检测不同遗传背景的大鼠对各种超排卵激素处理的反应。未成熟的斯普拉格 - 道利(SD)、FBNF1和F344雌性大鼠(30至35日龄)分别作为远交系、杂交系和近交系的代表用于本研究。每个品系的动物被分为四组进行如下激素处理:1)腹腔注射(i.p.)30 IU孕马血清促性腺激素(PMSG),52小时后腹腔注射25 IU人绒毛膜促性腺激素(HCG);2)腹腔注射15 IU PMSG,52小时后腹腔注射7.5 IU HCG;3)通过Alzet微型泵每天注射1.0 IU促卵泡激素(FSH),持续60小时;4)通过Alzet微型泵每天注射1.0 IU FSH,持续54小时,随后注射10 mg促黄体生成素(LH)。使用以下标准评估激素处理的效果:交配率、排卵率、每只雌性大鼠的总卵母细胞数和受精率。用PMSG(30)+HCG(25)处理的SD大鼠的交配率显著高于(P < 0.05)用PMSG(15)+HCG(7.5)处理的动物;此外,接受PMSG(30)+HCG(25)的SD动物每只雌性大鼠的总卵母细胞数显著高于(P < 0.05)所有其他处理。与所有其他处理相比,单独使用FSH处理时,SD大鼠的排卵率显著降低(P < 0.05)。与FSH和FSH+LH相比,FBNF1大鼠对两种PMSG+HCG处理的排卵率显著更高(P < 0.05)。与所有其他处理相比,单独使用FSH处理的F344大鼠的排卵率和受精率显著降低(P < 0.05)。与FSH和FHS+LH相比,F344大鼠对两种PMSG+HCG处理的每只雌性大鼠产生的卵母细胞显著更多(P < 0.05)。在FSH和FSH+LH处理下,SD和F344大鼠的排卵率显著高于(P < 0.05)FBNF1大鼠。在PMSG(30)+HCG(25)处理下,SD大鼠每只雌性大鼠产生的卵母细胞数量显著多于(P < 0.05)FBNF1大鼠;在FSH和FSH+LH处理下,与FBNF1和F344大鼠相比,SD大鼠每只雌性大鼠产生的卵母细胞数量显著更多(P < 0.05)。在PMSG(15)+HCG(7.5)处理下,SD和FBNF1大鼠的受精率显著高于(P < 0.05)F344大鼠。我们的研究表明,根据所检测的大多数标准,PMSG+HCG处理是引发超排卵反应的有效方法。我们还表明,与近交系和杂交系大鼠相比,远交系(SD)大鼠在激素刺激下通常每只雌性大鼠产生更多的卵母细胞。我们的结果表明,不同品系的大鼠对不同的超排卵方案具有不同程度的激素敏感性和反应。